Laurence Matthew Skelton serves as Chief Commercial Officer at Vera Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Laurence Matthew Skelton has executed 3 insider transactions totaling $66.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 23, 2026 involved selling 1,582 shares valued at $66.4K.
Laurence Matthew Skelton currently holds 64,218 shares of Vera Therapeutics, Inc. (VERA), valued at approximately $0. This represents their equity stake as Chief Commercial Officer.
Based on SEC Form 4 filings, Laurence Matthew Skelton has been a net seller of VERA stock. They have purchased $0 and sold $66.4K worth of shares.
Laurence Matthew Skelton's most recent insider trade was on Feb 23, 2026, when they sold 1,582 shares at $41.98 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 4, 2026 | VERA | $0 | Award | 20,000 | $N/A | Discretionary |